Distinguished Professor of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder
Cardiology, Molecular Biology, Human Genetic Disease
EDUCATION
BS – Cornell University
PhD – Yale University
Postdoctoral Fellow – Rockefeller University
AWARDS AND ACCOLADES
National Academy of Inventors, 2016
NHLBI MERIT Award
Distinguished Scientist Award, American Heart Association, 2017
Fellow, American Association for the Advancement of Science, 2005
Howard Hughes Medical Institutes Professor , 2006
Distinguished Professor, University of Colorado, Boulder
COMPANIES AND BOARDS
Co-Founder: MyoKardia (acquired by Bristol Myers Squibb), Myogen (acquired by Gilead Pharmaceuticals), Hiberna
Board of Directors: Hiberna, Global Down Syndrome Foundation
Scientific Advisory Board: Bristol Myers Squibb, Edgewise Therapeutics, Fulcrum Therapeutics, Linda Crnic Institute for Down Syndrome, Contour Therapeutics, TARA Biosystems
External Advisory Board: University of Arizona Department of Physiology; Indiana University School of Medicine; Stanford Cardiovascular Institute